MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) WilsonEncourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options If you suffered significant losses in MoonLake stock or options and would like to discuss your legal rights,call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310). […]

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

ROSEN, A LEADING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SVRA

NEW YORK CITY, NY / ACCESS Newswire / October 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ:SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the "Class Period"), of the important November 7, 2025 lead plaintiff deadline. SO WHAT:

PharmaCorp Refiles Q2 2025 Financial Statements

(TSX-V:PCRX), SASKATOON, Saskatchewan, Oct. 10, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV: PCRX) has restated and refiled its financial statements for the interim period ended June 30, 2025 (the “Amended Q2 2025 Statements“) as well as the corresponding management's discussion and analysis under PharmaCorp's profile on www.sedarplus.ca . In conjunction

PharmaCorp Refiles Q2 2025 Financial Statements

PharmaCorp Refiles Q2 2025 Financial Statements GlobeNewswire October 10, 2025 SASKATOON, Saskatchewan, Oct. 10, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV: PCRX) has restated and refiled its financial statements for the interim period ended June 30, 2025 (the “Amended Q2 2025 Statements“) as well as the corresponding management's discussion and

Banco Itau Chile Schedules Third Quarter 2025 Financial Results Conference Call

(Santiago:ITAUCL.SN), SANTIAGO, Chile, Oct. 10, 2025 (GLOBE NEWSWIRE) — BANCO ITAU CHILE (SSE: ITAUCL) announced today that it will release its results for the third quarter ended September 30, 2025, before the market opens in Santiago, on October 30, 2025. On Monday, November 10, 2025, at 12:00 P.M. Santiago time (10:00 A.M. ET), the Company's

Banco Itau Chile Schedules Third Quarter 2025 Financial Results Conference Call

Banco Itau Chile Schedules Third Quarter 2025 Financial Results Conference Call GlobeNewswire October 10, 2025 SANTIAGO, Chile, Oct. 10, 2025 (GLOBE NEWSWIRE) — BANCO ITAU CHILE (SSE: ITAUCL) announced today that it will release its results for the third quarter ended September 30, 2025, before the market opens in Santiago, on October 30, 2025. On

IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders

POTOMAC, MARYLAND / ACCESS Newswire / October 10, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer’s disease, today announced that during its Annual Meeting of Stockholders scheduled for and convened on October 10, 2025 (the "Annual Meeting"), all

CHTR FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Charter Communications, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Class Action – CHTR

NEW YORK CITY, NY / ACCESS Newswire / October 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities (as well as purchasers of call options or sellers of put options) of Charter Communications, Inc. (NASDAQ:CHTR) between July 26, 2024 and July 24, 2025, both dates inclusive (the

Scroll to Top